MARK HERMAN to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications MARK HERMAN has written about Diabetes Mellitus, Type 2.
Connection Strength
1.212
-
One small step for mice, one giant leap for GWAS? J Clin Invest. 2019 10 01; 129(10):4083-4085.
Score: 0.339
-
Regulation of Glucose Production in the Pathogenesis of Type 2 Diabetes. Curr Diab Rep. 2019 08 03; 19(9):77.
Score: 0.336
-
Pharmacologic blockade of the natriuretic peptide clearance receptor promotes weight loss and enhances insulin sensitivity in type 2 diabetes. Transl Res. 2023 05; 255:140-151.
Score: 0.106
-
Paradoxical activation of transcription factor SREBP1c and de novo lipogenesis by hepatocyte-selective ATP-citrate lyase depletion in obese mice. J Biol Chem. 2022 10; 298(10):102401.
Score: 0.104
-
Insulin action, type 2 diabetes, and branched-chain amino acids: A two-way street. Mol Metab. 2021 10; 52:101261.
Score: 0.095
-
Genetic Variants in CPA6 and PRPF31 Are Associated With Variation in Response to Metformin in Individuals With Type 2 Diabetes. Diabetes. 2018 07; 67(7):1428-1440.
Score: 0.077
-
Variation in glucose homeostasis traits associated with P2RX7 polymorphisms in mice and humans. J Clin Endocrinol Metab. 2015 May; 100(5):E688-96.
Score: 0.062
-
Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects. Cell. 2014 Oct 09; 159(2):318-32.
Score: 0.060
-
Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony. J Clin Invest. 2006 Jul; 116(7):1767-75.
Score: 0.034